Cargando…

Small-Molecule Proteomimetic Inhibitors of the HIF-1α–p300 Protein–Protein Interaction

The therapeutically relevant hypoxia inducible factor HIF-1α–p300 protein–protein interaction can be orthosterically inhibited with α-helix mimetics based on an oligoamide scaffold that recapitulates essential features of the C-terminal helix of the HIF-1α C-TAD (C-terminal transactivation domain)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Burslem, George M, Kyle, Hannah F, Breeze, Alexander L, Edwards, Thomas A, Nelson, Adam, Warriner, Stuart L, Wilson, Andrew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2014
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159589/ https://www.ncbi.nlm.nih.gov/pubmed/24782431 http://dx.doi.org/10.1002/cbic.201400009

Ejemplares similares

Towards “bionic” proteins: replacement of continuous sequences from HIF-1α with proteomimetics to create functional p300 binding HIF-1α mimics
por: Burslem, George M., et al.
Publicado: (2016)

Synthesis of highly functionalized oligobenzamide proteomimetic foldamers by late stage introduction of sensitive groups
por: Burslem, George M., et al.
Publicado: (2016)

Oligobenzamide proteomimetic inhibitors of the p53–hDM2 protein–protein interaction
por: Plante, Jeffrey P., et al.
Publicado: (2009)

Stereocontrolled protein surface recognition using chiral oligoamide proteomimetic foldamers
por: Azzarito, Valeria, et al.
Publicado: (2015)

Selective and Potent Proteomimetic Inhibitors of Intracellular Protein–Protein Interactions**
por: Barnard, Anna, et al.
Publicado: (2015)

Selective and Potent Proteomimetic Inhibitors of Intracellular Protein–Protein Interactions
por: Barnard, Anna, et al.
Publicado: (2015)

A catalytic protein–proteomimetic complex: using aromatic oligoamide foldamers as activators of RNase S
por: Hegedus, Zsofia, et al.
Publicado: (2019)

Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
por: Burslem, George M., et al.
Publicado: (2017)

Correction: Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
por: Burslem, George M., et al.
Publicado: (2017)

Correction: Correction: Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
por: Burslem, George M., et al.
Publicado: (2018)

Further Correction: Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
por: Burslem, George M., et al.
Publicado: (2018)

Stapled Peptides as HIF‐1α/p300 Inhibitors: Helicity Enhancement in the Bound State Increases Inhibitory Potency
por: Hetherington, Kristina, et al.
Publicado: (2020)

Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
por: Yang, Chao, et al.
Publicado: (2017)

Covalent Proteomimetic Inhibitor of the Bacterial FtsQB Divisome Complex
por: Paulussen, Felix M., et al.
Publicado: (2022)

Using proteomimetics to switch angiogenic signaling
por: Teng, Peng, et al.
Publicado: (2022)

Proteomimetic surface fragments distinguish targets by function
por: Tököli, Attila, et al.
Publicado: (2020)

Activity‐Directed Synthesis of Inhibitors of the p53/hDM2 Protein–Protein Interaction
por: Green, Adam I., et al.
Publicado: (2020)

A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein
por: Khatri, Bhavesh, et al.
Publicado: (2022)

Origin of Proteolytic Stability of Peptide-Brush Polymers as Globular Proteomimetics
por: Sun, Hao, et al.
Publicado: (2021)

Synthesis of New Proteomimetic Quinazolinone Alkaloids and Evaluation of Their Neuroprotective and Antitumor Effects
por: Long, Solida, et al.
Publicado: (2019)

Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
por: La Manna, Sara, et al.
Publicado: (2022)

Solid-Phase Methodology for Synthesis of O-Alkylated Aromatic Oligoamide Inhibitors of α-Helix-Mediated Protein–Protein Interactions
por: Murphy, Natasha S, et al.
Publicado: (2013)

Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds**
por: Morton, Daniel, et al.
Publicado: (2008)

Synthesis of skeletally diverse alkaloid-like molecules: exploitation of metathesis substrates assembled from triplets of building blocks
por: Maurya, Sushil K, et al.
Publicado: (2013)

Towards identification of protein–protein interaction stabilizers via inhibitory peptide-fragment hybrids using templated fragment ligation
por: Srdanović, Sonja, et al.
Publicado: (2022)

Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins
por: Deshmane, Satish L, et al.
Publicado: (2011)

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma
por: Viziteu, Elena, et al.
Publicado: (2016)

A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1α and p300/CBP through Direct Binding to the HIF1α C-Terminal Activation Domain
por: Wu, Donglu, et al.
Publicado: (2013)

Peroxisome protein import: a complex journey
por: Baker, Alison, et al.
Publicado: (2016)

Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
por: Choi, Wonmin, et al.
Publicado: (2023)

Targeting Protein–Protein Interactions in the HIF System
por: Wilkins, Sarah E., et al.
Publicado: (2016)

Phospholipase D1 protein coordinates dynamic assembly of HIF-1α-PHD-VHL to regulate HIF-1α stability
por: Park, Mi Hee, et al.
Publicado: (2014)

Trivalent Gd-DOTA reagents for modification of proteins
por: Fisher, Martin J., et al.
Publicado: (2015)

Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress
por: Zhang, Xiaodong, et al.
Publicado: (2018)

Small Molecules as Protein-Protein Interaction Inhibitors
por: Hajimahdi, Zahra
Publicado: (2016)

Characterization and functional analysis of hypoxia-inducible factor HIF1α and its inhibitor HIF1αn in tilapia
por: Li, Hong Lian, et al.
Publicado: (2017)

Action Sites and Clinical Application of HIF-1α Inhibitors
por: Xu, Renfeng, et al.
Publicado: (2022)

A Protein-Based Pentavalent Inhibitor of the Cholera Toxin B-Subunit**
por: Branson, Thomas R, et al.
Publicado: (2014)

HIF-1α as a Target Molecule in the Use of Triazino-Indole Derivative on the Acoustic Trauma Model
por: Pastushenkov, Vladimir L., et al.
Publicado: (2021)

USP10 Contributes to Colon Carcinogenesis via mTOR/S6K Mediated HIF-1α but Not HIF-2α Protein Synthesis
por: Kubaichuk, Kateryna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vad68f6hq86epj0fpn9845c2n1